89 results
Page 3 of 5
8-K
EX-1.1
6gkcxc
16 Dec 19
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
5:26pm
424B5
s6dvwz
16 Dec 19
Prospectus supplement for primary offering
5:23pm
424B5
wewwkt j8zugv
10 Dec 19
Prospectus supplement for primary offering
4:40pm
S-3
EX-4.3
wd6j5447j826gxg53d1y
11 Sep 19
Shelf registration
5:21pm
S-3
EX-1.2
jrtf161yjc1bj8v
11 Sep 19
Shelf registration
5:21pm
8-K
EX-10.1
9bn 27ivkwb8apfwwva
16 Jul 19
Aquestive Therapeutics Completes $70 Million Debt Refinancing
12:00am
8-K
EX-10.2
eybng147s780k
16 Jul 19
Aquestive Therapeutics Completes $70 Million Debt Refinancing
12:00am
DEF 14A
xw7hqtwqk6c7ebinv
26 Apr 19
Definitive proxy
11:18am
10-K
f70twugi1co6076
14 Mar 19
Annual report
2:04pm
8-K
EX-99.1
hr7uf4is6w5a
11 Dec 18
Regulation FD Disclosure
6:12am
8-K
EX-99.2
xsl3ritg
11 Dec 18
Regulation FD Disclosure
6:12am
424B4
g7rvro
26 Jul 18
Prospectus supplement with pricing info
4:52pm